Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01694368 · ClinicalTrials.gov registry record
Intracoronary Imaging With NIRS-IVUS to Characterize Arterial Plaques
A clinical trial, sponsored by Corewell Health West.
- Completed
- Registry status
- 500
- Enrollment target
NCT01694368: Completed study, sponsored by Corewell Health West.
NCT01694368 is a clinical trial that has completed, run by Corewell Health West. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01694368 has completed, sponsored by Corewell Health West.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
To characterize atherosclerotic coronary artery plaques using advanced intra-coronary imaging with a combined near-infrared spectroscopy and intravascular ultrasound catheter before and after percutaneous intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2011-11 |
| Est. Completion | 2021-09 |
What the finished NCT01694368 record still lists
NCT01694368 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01694368 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01694368 about?
NCT01694368 is a clinical study titled "Intracoronary Imaging With NIRS-IVUS to Characterize Arterial Plaques". To characterize atherosclerotic coronary artery plaques using advanced intra-coronary imaging with a combined near-infrared spectroscopy and intravascular ultrasound catheter before and after percutaneous intervention
What is the current status of trial NCT01694368?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2011-11. Estimated completion is 2021-09.
Who is sponsoring clinical trial NCT01694368?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia